Sort by
Refine Your Search
-
Employer
-
Field
-
centered around a unique, open-source digital platform enriched with data and powered by domain knowledge-based advanced machine learning and artificial intelligence capabilities. By introducing a Digital
-
intelligence, machine learning, statistical estimation methods, software tools, and big-data frameworks. Programming languages such as e.g. Python, C++, and LABVIEW. Emission control rules and regulations in
-
computer vision models for forest-based 3D point cloud data. In recent years, large advances have been made for deep learning algorithms for high-resolution point clouds from small geographic areas. We seek
-
detailed data about forest ecosystems. To convert the captured data into meaningful information about the forest environment we seek a PhD candidate who wishes to advance state-of-the-art computer vision
-
have an academically relevant background within Learning Technologies, Interaction Design, Human-Computer Interaction (HCI), Human-Centred Computing or alike. You must have a Master's degree in Computer
-
relevant background within Learning Technologies, Interaction Design, Human-Computer Interaction (HCI), Human-Centred Computing or alike. You must have a Master's degree in Computer Science or equivalent
-
fellow, PhD Candidate, research assistant, and specialist candidate. PLEASE NOTE: For detailed information about what the application must contain, see paragraph “About the application”. The appointment is
-
epidemiology, causal inference, genetic epidemiology, and machine learning. As a PhD candidate in the project, you will: Actively participate in group meetings, design statistical analysis plans in collaboration
-
that combine principled reasoning with the efficiency of modern machine learning to enable intelligent, real-time decision-making in large-scale interconnected systems. This position offers the opportunity
-
: WP1 will analyze large-scale registry data from the Nordic countries and England to assess the safety of modern ASMs. WP2 will investigate genetic, epigenetic, and pharmacological markers of ASM-related